Home » Stocks » Scholar Rock Holding

Scholar Rock Holding Corporation (SRRK)

Stock Price: $17.60 USD 0.15 (0.86%)
Updated Jul 2, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 525.78M
Revenue (ttm) 22.42M
Net Income (ttm) -57.32M
Shares Out 29.81M
EPS (ttm) -2.01
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Jul 2, 2020
Last Price $17.60
Previous Close $17.45
Change ($) 0.15
Change (%) 0.86%
Day's Open 17.70
Day's Range 17.16 - 17.80
Day's Volume 69,857
52-Week Range 6.95 - 21.92

More Stats

Market Cap 525.78M
Enterprise Value 367.67M
Earnings Date (est) Aug 5, 2020
Ex-Dividend Date n/a
Shares Outstanding 29.81M
Float 14.27M
EPS (basic) -2
EPS (diluted) -2.01
FCF / Share -1.61
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 1.87M
Short Ratio 16.46
Short % of Float 11.89%
Beta 0.84
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 23.46
PB Ratio 5.91
Revenue 22.42M
Operating Income -60.53M
Net Income -57.32M
Free Cash Flow -47.58M
Net Cash 158.11M
Net Cash / Share 5.29
Gross Margin -150.45%
Operating Margin -270.04%
Profit Margin -255.70%
FCF Margin -212.28%
ROA -21.83%
ROE -58.43%
ROIC -61.80%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (5)

Buy 4
Overweight 1
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$28.25*
(60.51% upside)
Low
22.0
Current: 17.60
High
35.0
Target: 28.25
*Average 12-month price target from 4 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016
Revenue20.49--0.38
Gross Profit20.49--0.38
Operating Income-54.54-50.69-25.03-16.21
Net Income-51.00-49.33-25.00-16.21
Shares Outstanding27.5415.661.631.60
Earnings Per Share-1.85-3.15-15.30-10.11
Operating Cash Flow-63.1224.57-21.74-15.14
Capital Expenditures-3.11-1.49-0.36-0.79
Free Cash Flow-66.2223.08-22.10-15.94
Cash & Equivalents16017658.1628.24
Total Debt5.300.421.041.67
Net Cash / Debt15517557.1326.57
Assets19618161.6432.78
Liabilities83.4874.715.934.75
Book Value113107-53.52-30.03
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Scholar Rock Holding Corporation
Country United States
Employees 93
CEO Nagesh K. Mahanthappa

Stock Information

Ticker Symbol SRRK
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: SRRK
IPO Date May 24, 2018

Description

Scholar Rock Holding Corporation, a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. Its lead antibody product candidate is SRK-015, a novel inhibitor of the activation of myostatin, which is in Phase II clinical trials for the treatment of spinal muscular atrophy. The company is also developing SRK-181, which is in Phase I clinical trials for the treatment of cancers that are resistant to checkpoint inhibitor therapies, such as anti-PD-1 or anti-PD-L1. In addition, it is developing a pipeline of novel product candidates for a range of serious diseases, including neuromuscular disorders, cancer, fibrosis, and anemia. The company has a collaboration agreement with Gilead Sciences, Inc. to discover and develop specific inhibitors of transforming growth factor beta activation for the treatment of fibrotic diseases. Scholar Rock Holding Corporation was founded in 2012 and is headquartered in Cambridge, Massachusetts.